Following stent implantation, neoatherosclerosis develops earlier and to a greater degree inside drug-eluting stents (DES) than bare-metal stents (BMS), according to an optical coherence tomography ...
RELATIVITY-047 trial met primary endpoint of progression-free survival Bristol Myers Squibb (BMS) has revealed top-line data from a Phase II/III trial evaluating its PD-1 inhibitor Opdivo plus its ...
In patients who develop cardiac allograft vasculopathy after heart transplantation, drug-eluting stents (DES) are more effective than bare-metal stents (BMS) while conferring no additional risk, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback